Dosage ; BPH: Oral: 0.4 mg once
daily ~30 minutes after the same meal each day;
dose may be increased after 2-4 weeks to 0.8 mg once daily in patients who
fail to respond. If therapy is interrupted for several days,
restart with 0.4 mg once daily.
Bladder outlet obstruction (unlabeled use):
Oral: 0.4 mg once daily ~30 minutes after the same meal each day
Combinations ; - see below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Contiflo OD | Ranbaxy Laboratories | Pharma Specialities Ltd. | 0.4mg | 10 | Tablet | per tablet | KES 689.00 |
| Contiflo OD | Ranbaxy Laboratories | Pharma Specialities Ltd. | 0.4mg | 10 | Tablet | per tablet | KES 675 |
| Tamsolin | Getz Pharmaceuticals | Surgipharm Ltd | 0.4mg | 10 | Tablet | per tablet | KES 661.00 |
| Flosure | Ferozsons Laboratories Ltd | Surgilinks Ltd. | 0.4mg | 20 | Tablet | per tablet | KES 900.00 |
| Tamsumac | Macleods Pharmaceuticals Ltd. | Sai Pharmaceuticals Ltd. | 0.4mg | 10 | Capsule | per capsule | KES 550.00 |
| Tamsulosin More info | |
|---|---|
| Mode Of Action | selective alpha1 adrenoreceptor-blocking agent. Blockade of a1-adrenoceptors can cause smooth muscles in the bladder neck and prostate to relax, resulting in an improvement in urine flow rate and reduction in symptoms in BPH. |
| Drug Indication | Benign prostatic hypertrophy. |
| Precautions | Prostate carcinoma; Pregnancy. |
| Contra-Indications | Hypersensitivity to sulfonamide; severe hepatic impairment; lactation |
| Side Effects | Hypersensitivity to sulfonamide; severe hepatic impairment; lactation |
| Special Information | Adult: 0.4mg OD, 30 min after same meal each day. Increase to 0.8mg OD after 2-4 wk where necessary. |
| Drug Category | DRUGS ACTING ON GENITO-URINARY SYSTEM |
| Drug Sub-Category | Other genito-urinary acting drugs
Dosing: Adult BPH: Oral: 0.4 mg once daily ~30 minutes after the same meal each day; dose may be increased after 2-4 weeks to 0.8 mg once daily in patients who fail to respond. If therapy is interrupted for several days, restart with 0.4 mg once daily. Bladder outlet obstruction (unlabeled use): Oral: 0.4 mg once daily ~30 minutes after the same meal each day Dosing: Geriatric Refer to adult dosing. Dosing: Renal Impairment Clcr ≥10 mL/minute: No adjustment needed. Clcr <10 mL/minute: Not studied. Dosing: Hepatic Impairment Mild-to-moderate impairment: No adjustment needed Severe impairment: Not studied Dosage Forms: U.S. Excipient information presented when available (limited, particularly for generics); consult specific product labeling. Capsule, oral, as hydrochloride: 0.4 mg Flomax®: 0.4 mg Tablet, oral, as hydrochloride: 0.4 mg Generic Equivalent Available: U.S. Yes Administration Administer 30 minutes after the same meal each day. Capsules should be swallowed whole; do not crush, chew, or open. Use Treatment of signs and symptoms of benign prostatic hyperplasia (BPH) Use - Unlabeled/Investigational Symptomatic treatment of bladder outlet obstruction or dysfunction |